{"cited_by_count":378231,"description":"This cluster of papers focuses on autoimmune encephalitis, particularly the clinical characteristics, diagnostic criteria, and management of conditions such as anti-NMDA receptor encephalitis, paraneoplastic syndromes, and limbic encephalitis. It explores the role of autoantibodies, immunotherapy, and the neurological manifestations of autoimmune diseases. Additionally, it discusses specific conditions like Hashimoto encephalopathy and cognitive impairment associated with these disorders.","display_name":"Autoimmune Neurological Disorders and Treatments","domain_id":"4","external_ids":{"openalex":"https://openalex.org/T11627","wikipedia":"https://en.wikipedia.org/wiki/Autoimmune_encephalitis"},"field_id":"27","id":"T11627","keywords":[{"display_name":"autoimmune encephalitis","id":"autoimmune-encephalitis","score":0.7726,"url":"https://openalex.org/keywords/autoimmune-encephalitis"},{"display_name":"anti-NMDA receptor encephalitis","id":"anti-nmda-receptor-encephalitis","score":0.8763,"url":"https://openalex.org/keywords/anti-nmda-receptor-encephalitis"},{"display_name":"paraneoplastic neurological syndromes","id":"paraneoplastic-neurological-syndrome","score":0.8209,"url":"https://openalex.org/keywords/paraneoplastic-neurological-syndrome"},{"display_name":"NMDA receptor antibodies","id":"anti-nmda-receptor-antibodies","score":0.8447,"url":"https://openalex.org/keywords/anti-nmda-receptor-antibodies"},{"display_name":"limbic encephalitis","id":"limbic-encephalitis","score":0.774,"url":"https://openalex.org/keywords/limbic-encephalitis"},{"display_name":"Hashimoto's encephalopathy","id":"hashimoto-s-encephalopathy","score":0.8497,"url":"https://openalex.org/keywords/hashimoto-s-encephalopathy"},{"display_name":"stiff person syndrome","id":"stiff-person-syndrome","score":0.4635,"url":"https://openalex.org/keywords/stiff-person-syndrome"},{"display_name":"glutamic acid decarboxylase antibodies","id":"gad-antibodies","score":0.2186,"url":"https://openalex.org/keywords/gad-antibodies"},{"display_name":"paraneoplastic cerebellar degeneration","id":"paraneoplastic-cerebellar-degeneration","score":0.8846,"url":"https://openalex.org/keywords/paraneoplastic-cerebellar-degeneration"},{"display_name":"anti-Hu antibodies","id":"anti-hu-antibodies","score":0.8337,"url":"https://openalex.org/keywords/anti-hu-antibodies"},{"display_name":"paraneoplastic encephalitis","id":"paraneoplastic-encephalitis","score":0.8726,"url":"https://openalex.org/keywords/paraneoplastic-encephalitis"},{"display_name":"opsoclonus-myoclonus syndrome","id":"opsoclonus-myoclonus-syndrome","score":0.587,"url":"https://openalex.org/keywords/opsoclonus-myoclonus-syndrome"},{"display_name":"LGI1 antibodies","id":"anti-lgi1-antibodies","score":0.918,"url":"https://openalex.org/keywords/anti-lgi1-antibodies"},{"display_name":"pediatric autoimmune encephalitis","id":"pediatric-autoimmune-encephalitis","score":0.8953,"url":"https://openalex.org/keywords/pediatric-autoimmune-encephalitis"},{"display_name":"antineuronal antibodies","id":"antineuronal-antibodies","score":0.6339,"url":"https://openalex.org/keywords/antineuronal-antibodies"},{"display_name":"anti-Yo antibodies","id":"anti-yo-antibodies","score":0.9173,"url":"https://openalex.org/keywords/anti-yo-antibodies"},{"display_name":"autoimmune neurological disorders","id":"autoimmune-neurological-disorders","score":0.4162,"url":"https://openalex.org/keywords/autoimmune-neurological-disorders"},{"display_name":"GAD65 antibodies","id":"gad65-autoantibodies","score":0.3171,"url":"https://openalex.org/keywords/gad65-autoantibodies"},{"display_name":"CASPR2 antibodies","id":"caspr2-antibodies","score":0.8683,"url":"https://openalex.org/keywords/caspr2-antibodies"},{"display_name":"autoimmune epilepsy","id":"autoimmune-epilepsy","score":0.6181,"url":"https://openalex.org/keywords/autoimmune-epilepsy"},{"display_name":"autoimmune encephalopathy","id":"autoimmune-encephalopathy","score":0.6861,"url":"https://openalex.org/keywords/autoimmune-encephalopathy"},{"display_name":"voltage-gated potassium channel antibodies","id":"voltage-gated-potassium-channel-antibodies","score":0.7778,"url":"https://openalex.org/keywords/voltage-gated-potassium-channel-antibodies"},{"display_name":"anti-LGI1 encephalitis","id":"anti-lgi1-encephalitis","score":0.9364,"url":"https://openalex.org/keywords/anti-lgi1-encephalitis"},{"display_name":"paraneoplastic limbic encephalitis","id":"paraneoplastic-limbic-encephalitis","score":0.9319,"url":"https://openalex.org/keywords/paraneoplastic-limbic-encephalitis"},{"display_name":"Rasmussen encephalitis","id":"rasmussen-encephalitis","score":0.2444,"url":"https://openalex.org/keywords/rasmussen-encephalitis"}],"legacy_keywords":["Anti-NMDA Receptor Encephalitis","Paraneoplastic Syndromes","Autoantibodies","Neurological Disorders","Immunotherapy","Limbic Encephalitis","Diagnostic Criteria","Neuronal Autoantigens","Hashimoto Encephalopathy","Cognitive Impairment"],"openalex_id":"https://openalex.org/T11627","source_created_date":"2024-01-23T15:27:11","source_updated_date":"2026-10-17T03:02:00","subfield_id":"2728","url":"/topics/T11627","works_api_url":"https://api.openalex.org/works?filter=topics.id:T11627","works_count":28180,"label":"Autoimmune Neurological Disorders and Treatments","provider":"openalex","revision":"0f6b6efd0b17c512","taxonomy_revision":"f050b5d4780b1289","title":"Autoimmune Neurological Disorders and Treatments","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"36249009802895786","address_version":"morton4x16-v1","coordinates":[4,27,2728,11627],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}